Top Markets
Coin of the day
Crossject Société Anonyme Crossject Société Anonyme

Crossject Société Anonyme

ALCJ
Rank in Stocks #12744
Crossject Société Anonyme develops needle-free injection systems. The company... Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.
Share Price
$2.02
Market Cap
$121.30M
Change (1 day)
-1.04%
Change (1 year)
-2.09%
Country
FR
Trade Crossject Société Anonyme (ALCJ)

Category

Earnings for Crossject Société Anonyme (ALCJ)
Earnings in Dec 2025 TTM: $-15.47M
According to Crossject Société Anonyme latest financial reports the company's current earnings are $-15.47M. In 2023 the company made an earning of $-12.72M, an increase over its 2022 earnings that were of $-14.35M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Crossject Société Anonyme from 2010 to 2026
Earnings at the end of each year
Year Earnings Change
2026 (TTM) $-15.47M -4.84%
2024 $-16.25M 27.80%
2023 $-12.72M -11.38%
2022 $-14.35M -0.03%
2021 $-14.36M 2.59%
2020 $-13.99M 46.56%
2019 $-9.55M -32.47%
2018 $-14.14M 34.82%
2017 $-10.49M 28.48%
2016 $-8.16M 11.67%
2015 $-7.31M 13.90%
2014 $-6.42M 95.21%
2013 $-3.29M 78.49%
2012 $-1.84M -292.97%
2011 $954.59K -114.97%
2010 $-6.38M 0.00%
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$3.58B -23,265.34%
US
$3.75B -24,333.92%
FR
$414.52M -2,779.78%
DE
$2.17B -14,118.05%
JP
$1.74B -11,342.30%
US